NEW
CLINICAL RESEARCH IN BRAZIL – NEW HORIZONS, NEW CHALLENGES
RECENT
ANVISA has just published the new version of the Cadifa Manual, but what were the main changes?
PSYCHEDELIC DRUGS
New Opportunities for the Pharmaceutical Market
ANVISA has just published the new version of the Cadifa Manual,
but what were the main changes?
Access
APPLIED KNOWLEDGE
In order to meet all the requirements of the new GMP legislation, we have expanded our portfolio of services in the area of Quality.
Solutions
WHO WE ARE
We are a service consultancy in the area of medicines and health products with great expertise in all stages of new product development
More
CUSTOMERS
We work with healthcare companies of all sizes with some of the largest pharmaceutical companies in Brazil and the world in our portfolio.
See more
See too
Cannabis: challenges and opportunities
API, BPF and drug dossier - How to align the processes to ensure success in registration?
NEW API REGULATORY FRAMEWORK: Will ANVISA and international manufacturers be prepared?
